Loading...
Thumbnail Image

Thesis

Browse

Search Results

Now showing 1 - 1 of 1
  • ThesisItemOpen Access
    HAEMATO – BIOCHEMICAL AND THERAPEUTIC ASPECTS OF EXOCRINE PANCREATIC INSUFFICIENCY IN CANINE
    (SRI VENKATESWARA VETERINARY UNIVERSITY TIRUPATI - 517 502. (A.P.) INDIA, 2008-10) Ambica, G; Tirumala Rao, D.S(MAJOR); Hamza, P.A; Gireesh Kumar
    ABSTRACT : The present clinical investigation was aimed at studying the incidence, clinical findings, haemato-biochemical parameters, therapy and therapeutic efficacy of certain drugs in Group I (Syp. Aristozyme and Tab. Aciloc), Group II (Tab. Festal – N, Inj. Pantova and Syp.Vitapep) and Group III (Syp. Digiplex-T, Inj. Pantova and Syp. Vitapep) dogs with Exocrine Pancreatic Insufficiency (EPI). A total of 76 dogs were presented with the history of passing loose, voluminous, grey coloured greasy faeces during the study period of February 2008 to July 2008. Out of them 54 dogs (71.05%) were loosing body weight in spite of normal appetite and showed the clinical signs of caprophagia, poor hair coat, flatulence and occasional vomiting in 37 (48.68%), 43 (56.58%), 21 (27.63) and 19 (25%) respectively. Faecal samples of all 76 dogs were screened for parasitic ova and all were found negative and further screened macroscopically for the presence of trypsin by x-ray film digestion test and microscopically for the presence of fat, starch and protein by standard procedures. Among these 18 dogs (23.68%) negative for faecal trypsin and presence of fat, starch and protein were screened in 34 (44.74%), 31 (40.79%) and 25 (32.89%) respectively. Further haemato biochemical estimation was done and 23.68 percent (18) tested were found positive for EPI. The age-wise, breed-wise and sex-wise incidence of EPI indicated the highest incidence among dogs belonging to 2-5 years (61.11%) age, German shepherds (66.66%) and males (72.22%), respectively. All the affected dogs showed no significant change in haematological parameters in all three groups. Among biochemical parameters, serum glucose and serum GGT found to be normal but serum Amylase and serum Lipase levels were found to be decreased. After therapy a significant (p<0.05) improvement was noticed. The therapeutic efficacy based on response to treatmen was observed to be comparatively higher in Group III (83.33 %) than in Group II (66.66 %) and Group I (33.33%) on day 7 of therapy. Based on the above findings the therapeutic regimen used in Group III, i.e. Syp. Digiplex-T (@ 5 ml BID orally), Inj. Pantova (Pantoprazole @ 0.5-1.0 mg/ Kg. Body Wt. I/m) and Syp. Vitapep (Vitamin Supplement with Pepsin @ 5 ml BID orally) could be recommended to achieve good therapeutic response in EPI positive dogs.